Microbiota–Gut–Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant-Based Treatments in Metabolic Diseases
Antioxidants · 21.04.2026 · 15 (4) · 522
DOI: 10.3390/antiox15040522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 21.04.2026. Verfasst von Jazmín Carro-Rodríguez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Neurociencia Traslacional, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic diseases are strongly associated with chronic systemic inflammation and oxidative stress, which disrupt the microbiota–gut–brain (MGB) axis and promote neuroinflammation. Dysbiosis favors the release of proinflammatory metabolites, reactive oxygen species (ROS), and lipopolysaccharides (LPS), increasing intestinal permeability and triggering systemic immune responses that reach the central nervous system (CNS) through a weakened blood–brain barrier (BBB). This review summarizes current knowledge on the pathophysiological mechanisms linking the MGB axis, metabolic disorders, and neuroinflammation, as well as the therapeutic potential of antioxidants. A literature search was conducted in PubMed, Web of Science, Scopus, and ScienceDirect and included original research articles, reviews, clinical trials, and meta-analyses related to microbiota, neuroinflammation, oxidative stress, and antioxidant interventions. Evidence indicates that dysbiosis exacerbates metabolic dysfunction by activating the nuclear factor kappa B (NF-κB) and NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome pathways, while excessive ROS production impairs mitochondrial function, neuronal survival, and cognitive processes. Antioxidant strategies, including polyphenols, omega-3 fatty acids, curcumin, vitamins C and E, and probiotics, can restore microbial diversity, reinforce intestinal and BBB integrity, and modulate oxidative and inflammatory signaling. In conclusion, supplements and bacteria with antioxidant properties show promising therapeutic effects by targeting oxidative stress mechanisms involved in metabolic diseases and their pathological consequences, such as dysbiosis and neuroinflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Neurociencia Traslacional, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Laboratorio de Microbiología y Biología Molecular, Departamento de Desarrollo de Tecnologías, Centro Interdisciplinario de Ciencias Marinas, Instituto Politécnico Nacional, La Paz 23096, Baja California Sur, Mexico.
- Laboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
- Sección de Investigación, Escuela Militar de Graduados de Sanidad, Centro de Investigación y Desarrollo del Ejército y Fuerza Aérea Mexicanos, Universidad del Ejército y Fuerza Aérea, Mexico City 11200, Mexico.
- Nutriología Clínica, Servicio de Endocrinología y Bariatria, Hospital Juárez de México, Mexico City 07760, Mexico.
- Facultad de Estudios Superiores de Iztacala, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico.
ORCID-Profile: Jazmín Carro-Rodríguez, Gabriela Ibáñez-Cervantes, Noemí Cárdenas-Rodríguez, Iván Ignacio-Mejía, Saúl Gómez-Manzo, Cindy Bandala
Zitieren
APA
Carro-Rodríguez, J., Ibáñez-Cervantes, G., Cárdenas-Rodríguez, N., Ignacio-Mejía, I., Albores-Méndez, E. M., Pardo-Pacheco, B. R., Fernández-Sánchez, V., Balboa-Verduzco, A. M., Adame, C., Lara-Padilla, E., Mancilla-Ramírez, J., Medina-Santillán, R., Montoya-Olvera, M., Cortes-Algara, A. L., Gómez-Manzo, S., Hernández-Ochoa, B., Moya-Amaya, H., & Bandala, C. (2026). Microbiota–Gut–Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant-Based Treatments in Metabolic Diseases. Antioxidants, 15(4), 522. https://doi.org/10.3390/antiox15040522
Vancouver
Carro-Rodríguez J, Ibáñez-Cervantes G, Cárdenas-Rodríguez N, Ignacio-Mejía I, Albores-Méndez EM, Pardo-Pacheco BR, et al. Microbiota–Gut–Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant-Based Treatments in Metabolic Diseases. Antioxidants. 2026;15(4):522. doi:10.3390/antiox15040522
BibTeX
@article{CarroRodrguez2026,
author = {Carro-Rodríguez, Jazmín and Ibáñez-Cervantes, Gabriela and Cárdenas-Rodríguez, Noemí and Ignacio-Mejía, Iván and Albores-Méndez, Exsal Manuel and Pardo-Pacheco, Blanca Rosalba and Fernández-Sánchez, Verónica and Balboa-Verduzco, Ana María and Adame, Cecilia and Lara-Padilla, Eleazar and Mancilla-Ramírez, Javier and Medina-Santillán, Roberto and Montoya-Olvera, Macarena and Cortes-Algara, Alfredo Leonardo and Gómez-Manzo, Saúl and Hernández-Ochoa, Beatriz and Moya-Amaya, Heliodoro and Bandala, Cindy},
title = {Microbiota–Gut–Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant-Based Treatments in Metabolic Diseases},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {522},
doi = {10.3390/antiox15040522}
}
EUVIMED